NYSSA • The New York State Society of Anesthesiologists, Inc.
Volume 78 Number 03
This new drug can integrate into anesthesia-based strategies and recovery pathways for treating acute postsurgical pain—and be included in opioid stewardship efforts. It is the first FDA-approved non-opioid medication that represents a groundbreaking advancement in acute pain management.
You'll have to be logged in to keep reading.
Website design, development and hosting by MAjor Designs